APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Latanoprost API

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Latanoprost API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174006630331 December 2025198 pages

Choose your research edition.

Industry ResearchLatanoprost API Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Latanoprost API Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Latanoprost API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Latanoprost API Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Latanoprost API Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Latanoprost API market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Latanoprost API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Latanoprost API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Latanoprost API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Latanoprost API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Latanoprost API include Sanofi, Guangzhou Tosun Pharmaceutical, Ausun Pharm, Summit Pharmaceuticals, NEWCHEM, Gentec Pharmaceutical Group, Fleming Laboratories, Euroapi and Dr Pradeep Reddy’s Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Latanoprost API market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Latanoprost API and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Latanoprost API sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Latanoprost API market size, projected growth trends, production technologies, key applications, and end-use industries.

Latanoprost API Segment by Company

Sanofi

Guangzhou Tosun Pharmaceutical

Ausun Pharm

Summit Pharmaceuticals

NEWCHEM

Gentec Pharmaceutical Group

Fleming Laboratories

Euroapi

Dr Pradeep Reddy’s Laboratories

DongWha Pharm

DEAFARMA

Chemo

Century Pharmaceuticals

Cayman Pharma

Berr Chemical

Aspen Biopharma

Latanoprost API Segment by Type

Liquid

Powder

Latanoprost API Segment by Application

Glaucoma

High Eye Pressure

Others

Latanoprost API Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Latanoprost API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Latanoprost API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Latanoprost API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Latanoprost API market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Latanoprost API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Latanoprost API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Latanoprost API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Latanoprost API Industry Trends Table 2. Latanoprost API Industry Drivers Table 3. Latanoprost API Industry Opportunities and Challenges Table 4. Latanoprost API Industry Restraints Table 5. Global Latanoprost API Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Latanoprost API Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Latanoprost API Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Latanoprost API Sales Market Share by Manufacturers Table 9. Global Latanoprost API Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Latanoprost API Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Latanoprost API Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Latanoprost API Manufacturers, Product Type & Application Table 13. Global Latanoprost API Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Latanoprost API by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Liquid Table 17. Major Manufacturers of Powder Table 18. Global Latanoprost API Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Latanoprost API Sales by Type (2021-2026) & (K Units) Table 20. Global Latanoprost API Sales by Type (2027-2032) & (K Units) Table 21. Global Latanoprost API Sales Market Share by Type (2021-2026) Table 22. Global Latanoprost API Sales Market Share by Type (2027-2032) Table 23. Global Latanoprost API Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Latanoprost API Revenue by Type (2021-2026) & (K Units) Table 25. Global Latanoprost API Revenue by Type (2027-2032) & (K Units) Table 26. Global Latanoprost API Revenue Market Share by Type (2021-2026) Table 27. Global Latanoprost API Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Glaucoma Table 29. Major Manufacturers of High Eye Pressure Table 30. Major Manufacturers of Others Table 31. Global Latanoprost API Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Latanoprost API Sales by Application (2021-2026) & (K Units) Table 33. Global Latanoprost API Sales by Application (2027-2032) & (K Units) Table 34. Global Latanoprost API Sales Market Share by Application (2021-2026) Table 35. Global Latanoprost API Sales Market Share by Application (2027-2032) Table 36. Global Latanoprost API Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Latanoprost API Revenue by Application (2021-2026) & (K Units) Table 38. Global Latanoprost API Revenue by Application (2027-2032) & (K Units) Table 39. Global Latanoprost API Revenue Market Share by Application (2021-2026) Table 40. Global Latanoprost API Revenue Market Share by Application (2027-2032) Table 41. Global Latanoprost API Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Latanoprost API Sales by Region (2021-2026) & (K Units) Table 43. Global Latanoprost API Sales Market Share by Region (2021-2026) Table 44. Global Latanoprost API Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Latanoprost API Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Latanoprost API Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Latanoprost API Sales by Country (2021-2026) & (K Units) Table 48. North America Latanoprost API Sales by Country (2027-2032) & (K Units) Table 49. Europe Latanoprost API Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Latanoprost API Sales by Country (2021-2026) & (K Units) Table 51. Europe Latanoprost API Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Latanoprost API Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Latanoprost API Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Latanoprost API Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Latanoprost API Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Latanoprost API Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Latanoprost API Sales by Country (2027-2032) & (K Units) Table 58. Global Latanoprost API Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Latanoprost API Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Latanoprost API Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Latanoprost API Revenue Market Share by Region (2021-2026) Table 62. Global Latanoprost API Revenue Market Share by Region (2027-2032) Table 63. Sanofi Company Information Table 64. Sanofi Business Overview Table 65. Sanofi Latanoprost API Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Sanofi Latanoprost API Product Portfolio Table 67. Sanofi Recent Development Table 68. Guangzhou Tosun Pharmaceutical Company Information Table 69. Guangzhou Tosun Pharmaceutical Business Overview Table 70. Guangzhou Tosun Pharmaceutical Latanoprost API Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Guangzhou Tosun Pharmaceutical Latanoprost API Product Portfolio Table 72. Guangzhou Tosun Pharmaceutical Recent Development Table 73. Ausun Pharm Company Information Table 74. Ausun Pharm Business Overview Table 75. Ausun Pharm Latanoprost API Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Ausun Pharm Latanoprost API Product Portfolio Table 77. Ausun Pharm Recent Development Table 78. Summit Pharmaceuticals Company Information Table 79. Summit Pharmaceuticals Business Overview Table 80. Summit Pharmaceuticals Latanoprost API Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Summit Pharmaceuticals Latanoprost API Product Portfolio Table 82. Summit Pharmaceuticals Recent Development Table 83. NEWCHEM Company Information Table 84. NEWCHEM Business Overview Table 85. NEWCHEM Latanoprost API Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. NEWCHEM Latanoprost API Product Portfolio Table 87. NEWCHEM Recent Development Table 88. Gentec Pharmaceutical Group Company Information Table 89. Gentec Pharmaceutical Group Business Overview Table 90. Gentec Pharmaceutical Group Latanoprost API Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Gentec Pharmaceutical Group Latanoprost API Product Portfolio Table 92. Gentec Pharmaceutical Group Recent Development Table 93. Fleming Laboratories Company Information Table 94. Fleming Laboratories Business Overview Table 95. Fleming Laboratories Latanoprost API Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Fleming Laboratories Latanoprost API Product Portfolio Table 97. Fleming Laboratories Recent Development Table 98. Euroapi Company Information Table 99. Euroapi Business Overview Table 100. Euroapi Latanoprost API Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Euroapi Latanoprost API Product Portfolio Table 102. Euroapi Recent Development Table 103. Dr Pradeep Reddy’s Laboratories Company Information Table 104. Dr Pradeep Reddy’s Laboratories Business Overview Table 105. Dr Pradeep Reddy’s Laboratories Latanoprost API Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Dr Pradeep Reddy’s Laboratories Latanoprost API Product Portfolio Table 107. Dr Pradeep Reddy’s Laboratories Recent Development Table 108. DongWha Pharm Company Information Table 109. DongWha Pharm Business Overview Table 110. DongWha Pharm Latanoprost API Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. DongWha Pharm Latanoprost API Product Portfolio Table 112. DongWha Pharm Recent Development Table 113. DEAFARMA Company Information Table 114. DEAFARMA Business Overview Table 115. DEAFARMA Latanoprost API Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. DEAFARMA Latanoprost API Product Portfolio Table 117. DEAFARMA Recent Development Table 118. Chemo Company Information Table 119. Chemo Business Overview Table 120. Chemo Latanoprost API Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Chemo Latanoprost API Product Portfolio Table 122. Chemo Recent Development Table 123. Century Pharmaceuticals Company Information Table 124. Century Pharmaceuticals Business Overview Table 125. Century Pharmaceuticals Latanoprost API Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Century Pharmaceuticals Latanoprost API Product Portfolio Table 127. Century Pharmaceuticals Recent Development Table 128. Cayman Pharma Company Information Table 129. Cayman Pharma Business Overview Table 130. Cayman Pharma Latanoprost API Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Cayman Pharma Latanoprost API Product Portfolio Table 132. Cayman Pharma Recent Development Table 133. Berr Chemical Company Information Table 134. Berr Chemical Business Overview Table 135. Berr Chemical Latanoprost API Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Berr Chemical Latanoprost API Product Portfolio Table 137. Berr Chemical Recent Development Table 138. Aspen Biopharma Company Information Table 139. Aspen Biopharma Business Overview Table 140. Aspen Biopharma Latanoprost API Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Aspen Biopharma Latanoprost API Product Portfolio Table 142. Aspen Biopharma Recent Development Table 143. Key Raw Materials Table 144. Raw Materials Key Suppliers Table 145. Latanoprost API Distributors List Table 146. Latanoprost API Customers List Table 147. Research Programs/Design for This Report Table 148. Authors List of This Report Table 149. Secondary Sources Table 150. Primary Sources List of Figures Figure 1. Latanoprost API Product Image Figure 2. Global Latanoprost API Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Latanoprost API Market Size (2021-2032) & (US$ Million) Figure 4. Global Latanoprost API Sales (2021-2032) & (K Units) Figure 5. Global Latanoprost API Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Latanoprost API Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Liquid Image Figure 9. Powder Image Figure 10. Global Latanoprost API Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Latanoprost API Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Latanoprost API Sales Market Share by Type (2021-2032) Figure 13. Global Latanoprost API Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Latanoprost API Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Latanoprost API Revenue Market Share by Type (2021-2032) Figure 16. Glaucoma Image Figure 17. High Eye Pressure Image Figure 18. Others Image Figure 19. Global Latanoprost API Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Latanoprost API Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Latanoprost API Sales Market Share by Application (2021-2032) Figure 22. Global Latanoprost API Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Latanoprost API Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Latanoprost API Revenue Market Share by Application (2021-2032) Figure 25. North America Latanoprost API Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Latanoprost API Sales Market Share by Country (2021-2032) Figure 27. U.S. Latanoprost API Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Latanoprost API Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Latanoprost API Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Latanoprost API Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Latanoprost API Sales Market Share by Country (2021-2032) Figure 32. Germany Latanoprost API Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Latanoprost API Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Latanoprost API Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Latanoprost API Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Latanoprost API Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Latanoprost API Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Latanoprost API Sales Market Share by Country (2021-2032) Figure 39. China Latanoprost API Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Latanoprost API Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Latanoprost API Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Latanoprost API Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Latanoprost API Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Latanoprost API Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Latanoprost API Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Latanoprost API Sales Market Share by Country (2021-2032) Figure 47. Brazil Latanoprost API Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Latanoprost API Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Latanoprost API Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Latanoprost API Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Latanoprost API Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Latanoprost API Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Latanoprost API Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Latanoprost API Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Latanoprost API Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Latanoprost API Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Latanoprost API Revenue (2021-2032) & (US$ Million) Figure 58. North America Latanoprost API Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Latanoprost API Revenue (2021-2032) & (US$ Million) Figure 60. Europe Latanoprost API Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Latanoprost API Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Latanoprost API Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Latanoprost API Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Latanoprost API Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latanoprost API Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Latanoprost API Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Liquid
  • Powder
Applications
  • Glaucoma
  • High Eye Pressure
  • Others
Companies covered
  • Sanofi
  • Guangzhou Tosun Pharmaceutical
  • Ausun Pharm
  • Summit Pharmaceuticals
  • NEWCHEM
  • Gentec Pharmaceutical Group
  • Fleming Laboratories
  • Euroapi
  • Dr Pradeep Reddy’s Laboratories
  • DongWha Pharm
  • DEAFARMA
  • Chemo
  • Century Pharmaceuticals
  • Cayman Pharma
  • Berr Chemical
  • Aspen Biopharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Latanoprost API Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Latanoprost API Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Latanoprost API Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Latanoprost API Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Latanoprost API Market Dynamics
  1. 2.1 Latanoprost API Industry Trends
  2. 2.2 Latanoprost API Industry Drivers
  3. 2.3 Latanoprost API Industry Opportunities and Challenges
  4. 2.4 Latanoprost API Industry Restraints
3 Latanoprost API Market by Manufacturers
  1. 3.1 Global Latanoprost API Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Latanoprost API Sales by Manufacturers (2021-2026)
  3. 3.3 Global Latanoprost API Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Latanoprost API Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Latanoprost API Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Latanoprost API Manufacturers, Product Type & Application
  7. 3.7 Global Latanoprost API Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Latanoprost API Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Latanoprost API Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Latanoprost API Tier 1, Tier 2, and Tier 3
4 Latanoprost API Market by Type
  1. 4.1 Latanoprost API Type Introduction
  2. 4.1.1 Liquid
  3. 4.1.2 Powder
  4. 4.2 Global Latanoprost API Sales by Type
  5. 4.2.1 Global Latanoprost API Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Latanoprost API Sales by Type (2021-2032)
  7. 4.2.3 Global Latanoprost API Sales Market Share by Type (2021-2032)
  8. 4.3 Global Latanoprost API Revenue by Type
  9. 4.3.1 Global Latanoprost API Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Latanoprost API Revenue by Type (2021-2032)
  11. 4.3.3 Global Latanoprost API Revenue Market Share by Type (2021-2032)
5 Latanoprost API Market by Application
  1. 5.1 Latanoprost API Application Introduction
  2. 5.1.1 Glaucoma
  3. 5.1.2 High Eye Pressure
  4. 5.1.3 Others
  5. 5.2 Global Latanoprost API Sales by Application
  6. 5.2.1 Global Latanoprost API Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Latanoprost API Sales by Application (2021-2032)
  8. 5.2.3 Global Latanoprost API Sales Market Share by Application (2021-2032)
  9. 5.3 Global Latanoprost API Revenue by Application
  10. 5.3.1 Global Latanoprost API Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Latanoprost API Revenue by Application (2021-2032)
  12. 5.3.3 Global Latanoprost API Revenue Market Share by Application (2021-2032)
6 Global Latanoprost API Sales by Region
  1. 6.1 Global Latanoprost API Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Latanoprost API Sales by Region (2021-2032)
  3. 6.2.1 Global Latanoprost API Sales by Region (2021-2026)
  4. 6.2.2 Global Latanoprost API Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Latanoprost API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Latanoprost API Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Latanoprost API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Latanoprost API Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Latanoprost API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Latanoprost API Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Latanoprost API Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Latanoprost API Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Latanoprost API Revenue by Region
  1. 7.1 Global Latanoprost API Revenue by Region
  2. 7.1.1 Global Latanoprost API Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Latanoprost API Revenue by Region (2021-2026)
  4. 7.1.3 Global Latanoprost API Revenue by Region (2027-2032)
  5. 7.1.4 Global Latanoprost API Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Latanoprost API Revenue (2021-2032)
  8. 7.2.2 North America Latanoprost API Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Latanoprost API Revenue (2021-2032)
  11. 7.3.2 Europe Latanoprost API Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Latanoprost API Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Latanoprost API Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Latanoprost API Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Latanoprost API Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Latanoprost API Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Latanoprost API Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 Guangzhou Tosun Pharmaceutical
  8. 8.2.1 Guangzhou Tosun Pharmaceutical Company Information
  9. 8.2.2 Guangzhou Tosun Pharmaceutical Business Overview
  10. 8.2.3 Guangzhou Tosun Pharmaceutical Latanoprost API Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Guangzhou Tosun Pharmaceutical Latanoprost API Product Portfolio
  12. 8.2.5 Guangzhou Tosun Pharmaceutical Recent Developments
  13. 8.3 Ausun Pharm
  14. 8.3.1 Ausun Pharm Company Information
  15. 8.3.2 Ausun Pharm Business Overview
  16. 8.3.3 Ausun Pharm Latanoprost API Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Ausun Pharm Latanoprost API Product Portfolio
  18. 8.3.5 Ausun Pharm Recent Developments
  19. 8.4 Summit Pharmaceuticals
  20. 8.4.1 Summit Pharmaceuticals Company Information
  21. 8.4.2 Summit Pharmaceuticals Business Overview
  22. 8.4.3 Summit Pharmaceuticals Latanoprost API Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Summit Pharmaceuticals Latanoprost API Product Portfolio
  24. 8.4.5 Summit Pharmaceuticals Recent Developments
  25. 8.5 NEWCHEM
  26. 8.5.1 NEWCHEM Company Information
  27. 8.5.2 NEWCHEM Business Overview
  28. 8.5.3 NEWCHEM Latanoprost API Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 NEWCHEM Latanoprost API Product Portfolio
  30. 8.5.5 NEWCHEM Recent Developments
  31. 8.6 Gentec Pharmaceutical Group
  32. 8.6.1 Gentec Pharmaceutical Group Company Information
  33. 8.6.2 Gentec Pharmaceutical Group Business Overview
  34. 8.6.3 Gentec Pharmaceutical Group Latanoprost API Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Gentec Pharmaceutical Group Latanoprost API Product Portfolio
  36. 8.6.5 Gentec Pharmaceutical Group Recent Developments
  37. 8.7 Fleming Laboratories
  38. 8.7.1 Fleming Laboratories Company Information
  39. 8.7.2 Fleming Laboratories Business Overview
  40. 8.7.3 Fleming Laboratories Latanoprost API Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Fleming Laboratories Latanoprost API Product Portfolio
  42. 8.7.5 Fleming Laboratories Recent Developments
  43. 8.8 Euroapi
  44. 8.8.1 Euroapi Company Information
  45. 8.8.2 Euroapi Business Overview
  46. 8.8.3 Euroapi Latanoprost API Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Euroapi Latanoprost API Product Portfolio
  48. 8.8.5 Euroapi Recent Developments
  49. 8.9 Dr Pradeep Reddy’s Laboratories
  50. 8.9.1 Dr Pradeep Reddy’s Laboratories Company Information
  51. 8.9.2 Dr Pradeep Reddy’s Laboratories Business Overview
  52. 8.9.3 Dr Pradeep Reddy’s Laboratories Latanoprost API Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Dr Pradeep Reddy’s Laboratories Latanoprost API Product Portfolio
  54. 8.9.5 Dr Pradeep Reddy’s Laboratories Recent Developments
  55. 8.10 DongWha Pharm
  56. 8.10.1 DongWha Pharm Company Information
  57. 8.10.2 DongWha Pharm Business Overview
  58. 8.10.3 DongWha Pharm Latanoprost API Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 DongWha Pharm Latanoprost API Product Portfolio
  60. 8.10.5 DongWha Pharm Recent Developments
  61. 8.11 DEAFARMA
  62. 8.11.1 DEAFARMA Company Information
  63. 8.11.2 DEAFARMA Business Overview
  64. 8.11.3 DEAFARMA Latanoprost API Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 DEAFARMA Latanoprost API Product Portfolio
  66. 8.11.5 DEAFARMA Recent Developments
  67. 8.12 Chemo
  68. 8.12.1 Chemo Company Information
  69. 8.12.2 Chemo Business Overview
  70. 8.12.3 Chemo Latanoprost API Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Chemo Latanoprost API Product Portfolio
  72. 8.12.5 Chemo Recent Developments
  73. 8.13 Century Pharmaceuticals
  74. 8.13.1 Century Pharmaceuticals Company Information
  75. 8.13.2 Century Pharmaceuticals Business Overview
  76. 8.13.3 Century Pharmaceuticals Latanoprost API Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Century Pharmaceuticals Latanoprost API Product Portfolio
  78. 8.13.5 Century Pharmaceuticals Recent Developments
  79. 8.14 Cayman Pharma
  80. 8.14.1 Cayman Pharma Company Information
  81. 8.14.2 Cayman Pharma Business Overview
  82. 8.14.3 Cayman Pharma Latanoprost API Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Cayman Pharma Latanoprost API Product Portfolio
  84. 8.14.5 Cayman Pharma Recent Developments
  85. 8.15 Berr Chemical
  86. 8.15.1 Berr Chemical Company Information
  87. 8.15.2 Berr Chemical Business Overview
  88. 8.15.3 Berr Chemical Latanoprost API Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Berr Chemical Latanoprost API Product Portfolio
  90. 8.15.5 Berr Chemical Recent Developments
  91. 8.16 Aspen Biopharma
  92. 8.16.1 Aspen Biopharma Company Information
  93. 8.16.2 Aspen Biopharma Business Overview
  94. 8.16.3 Aspen Biopharma Latanoprost API Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Aspen Biopharma Latanoprost API Product Portfolio
  96. 8.16.5 Aspen Biopharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Latanoprost API Value Chain Analysis
  2. 9.1.1 Latanoprost API Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Latanoprost API Production Mode & Process
  6. 9.2 Latanoprost API Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Latanoprost API Distributors
  9. 9.2.3 Latanoprost API Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst